内部人交易记录
其他基于 5 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the complete record of transactions filed by Connealy Pamela Ann. Insider active across 2 companies, notably Orchestra BioMed Holdings, Inc.. Cumulatively, 13 filings have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €63k. History available since 20 July 2023. The latest transaction was disclosed on 7 August 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Connealy Pamela Ann
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
17,327 股Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-077775:0
15,000 股0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-075786:0
12,422 股0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-25-063095:0
5,450 股@ US$2.009.5% 占其流量Common StockSEC:0000950170-24-131606:0
5,376 股0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-24-074013:0
328,710 股0Common StockSEC:0000950170-24-038108:0
36,949 股@ US$1.4042.7% 占其流量Common StockSEC:0001209191-23-056969:0
8,000 股@ US$1.8727.0% 占其流量Common StockSEC:0001209191-23-050734:0
6,426 股@ US$1.846821.5% 占其流量Common StockSEC:0001209191-23-050685:0
12,000 股@ US$1.670336.0% 占其流量Common StockSEC:0001209191-23-050492:0
5,000 股@ US$1.73915.5% 占其流量Common StockSEC:0001209191-23-050432:0
187,793 股0Common StockSEC:0001209191-23-048819:0
11,667 股0Common Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-23-083499:0
About Connealy Pamela Ann
Connealy Pamela Ann is a declarant with 13 filings in total. The 13 sampled filings, covering the period from 2023-07-24 to 2026-06-25, show EUR 62976 in buys and EUR 0 in sells, with the modal transaction nature listed as Attribution. She is linked to Pyxis Oncology, Inc. as CFO & COO and to Orchestra BioMed Holdings, Inc. as Director.